AZD3355 Dose-escalation Study in Healthy Males

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The aim is to establish the maximal tolerated dose of AZD3355 for the selection of doses in the up-coming studies. This will be done by comparing single and repeated doses of AZD3355 to placebo (\"inactive substance\"). Safety and tolerability variables will be closely monitored throughout the study.
Epistemonikos ID: b8628daccb8929b9774e590e5cf9083e5482c27f
First added on: May 05, 2024